Q1 2022 13F Holders as of 3/31/2022
-
Type / Class
-
Equity / ISIN
-
Number of holders
-
209
-
Total shares
-
129M
-
Shares change
-
+36.9M
-
Total reported value, excl. options
-
$300M
-
Value change
-
+$77M
-
Put/Call ratio
-
0.53
-
Number of buys
-
120
-
Number of sells
-
-61
-
Price
-
$2.33
Significant Holders of SORRENTO THERAPEUTICS INC - ISIN (SRNE) as of Q1 2022
218 filings reported holding SRNE - SORRENTO THERAPEUTICS INC - ISIN as of Q1 2022.
SORRENTO THERAPEUTICS INC - ISIN (SRNE) has 209 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 129M shares
.
Largest 10 shareholders include STATE STREET CORP (34M shares), BlackRock Inc. (22M shares), VANGUARD GROUP INC (15.9M shares), D. E. Shaw & Co., Inc. (7.24M shares), GEODE CAPITAL MANAGEMENT, LLC (4.99M shares), JPMORGAN CHASE & CO (3.3M shares), MORGAN STANLEY (3.28M shares), NORTHERN TRUST CORP (2.82M shares), UBS Group AG (2.48M shares), and Rafferty Asset Management, LLC (2.47M shares).
This table shows the top 209 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.